DTCFF
Price
$0.66
Change
+$0.05 (+8.20%)
Updated
Dec 3 closing price
Capitalization
36.04M
Intraday BUY SELL Signals
VALN
Price
$8.65
Change
-$0.12 (-1.37%)
Updated
Dec 3 closing price
Capitalization
802.13M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DTCFF vs VALN

Header iconDTCFF vs VALN Comparison
Open Charts DTCFF vs VALNBanner chart's image
DEFENCE THERAPEUTICS
Price$0.66
Change+$0.05 (+8.20%)
Volume$78.49K
Capitalization36.04M
Valneva SE
Price$8.65
Change-$0.12 (-1.37%)
Volume$11.99K
Capitalization802.13M
DTCFF vs VALN Comparison Chart in %
DTCFF
Daily Signal:
Gain/Loss:
VALN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DTCFF vs. VALN commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCFF is a Hold and VALN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (DTCFF: $0.57 vs. VALN: $8.77)
Brand notoriety: DTCFF and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTCFF: 196% vs. VALN: 55%
Market capitalization -- DTCFF: $36.04M vs. VALN: $802.13M
DTCFF [@Biotechnology] is valued at $36.04M. VALN’s [@Biotechnology] market capitalization is $802.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTCFF’s FA Score shows that 0 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • DTCFF’s FA Score: 0 green, 5 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than DTCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTCFF’s TA Score shows that 3 TA indicator(s) are bullish while VALN’s TA Score has 5 bullish TA indicator(s).

  • DTCFF’s TA Score: 3 bullish, 5 bearish.
  • VALN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VALN is a better buy in the short-term than DTCFF.

Price Growth

DTCFF (@Biotechnology) experienced а +0.37% price change this week, while VALN (@Biotechnology) price change was +0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

VALN is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($802M) has a higher market cap than DTCFF($36M). VALN YTD gains are higher at: 100.595 vs. DTCFF (46.916). DTCFF has higher annual earnings (EBITDA): -3.16M vs. VALN (-20.38M). VALN has more cash in the bank: 161M vs. DTCFF (2.08M). DTCFF has less debt than VALN: DTCFF (1.39M) vs VALN (197M). VALN has higher revenues than DTCFF: VALN (196M) vs DTCFF (0).
DTCFFVALNDTCFF / VALN
Capitalization36M802M4%
EBITDA-3.16M-20.38M16%
Gain YTD46.916100.59547%
P/E RatioN/AN/A-
Revenue0196M-
Total Cash2.08M161M1%
Total Debt1.39M197M1%
TECHNICAL ANALYSIS
Technical Analysis
DTCFFVALN
RSI
ODDS (%)
Bearish Trend 7 days ago
79%
Bullish Trend 7 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
57%
Bullish Trend 7 days ago
76%
Momentum
ODDS (%)
Bearish Trend 7 days ago
73%
Bullish Trend 7 days ago
76%
MACD
ODDS (%)
Bearish Trend 7 days ago
68%
Bullish Trend 7 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
54%
Bullish Trend 7 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
48%
Bullish Trend 7 days ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
62%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
56%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
75%
Bearish Trend 7 days ago
84%
Aroon
ODDS (%)
Bullish Trend 7 days ago
71%
Bearish Trend 7 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DTCFF
Daily Signal:
Gain/Loss:
VALN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTEYX50.77N/A
N/A
Gateway Y
LEAIX15.59N/A
N/A
Lazard Emerging Markets Eq Advtg Instl
HROAX13.13N/A
N/A
M3Sixty Income and Opportunity A
WOFRX65.60N/A
N/A
Allspring Opportunity R6
VVICX11.47N/A
N/A
VOYA VACS Index Series SC Portfolio

DTCFF and

Correlation & Price change

A.I.dvisor tells us that DTCFF and VERA have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTCFF and VERA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTCFF
1D Price
Change %
DTCFF100%
N/A
VERA - DTCFF
14%
Poorly correlated
+12.88%
BRNS - DTCFF
11%
Poorly correlated
-8.38%
MOLN - DTCFF
7%
Poorly correlated
+5.72%
VALN - DTCFF
6%
Poorly correlated
-1.57%
LYEL - DTCFF
5%
Poorly correlated
-6.70%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
-1.57%
INRLF - VALN
42%
Loosely correlated
N/A
ORKA - VALN
35%
Loosely correlated
+0.56%
PTCT - VALN
32%
Poorly correlated
-0.89%
IPHA - VALN
32%
Poorly correlated
+2.63%
SYRE - VALN
29%
Poorly correlated
-0.91%
More